Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Insight Partners | PRODUCT CODE: 1141905

Cover Image

PUBLISHER: The Insight Partners | PRODUCT CODE: 1141905

Monoclonal Antibody Diagnostic Reagent Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Tests and Application

PUBLISHED:
PAGES: 252 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF (Single User License)
USD 4550
PDF (Site License)
USD 6550
PDF (Enterprise License)
USD 8550

Add to Cart

The monoclonal antibody diagnostic reagent market is expected to grow from US$ 7,654.06 million in 2021 to US$ 18,507.20 million by 2028; it is expected to grow with a CAGR of 13.5% from 2022 to 2028.

The rising prevalence of cancer & other chronic diseases, extensive R&D efforts to develop novel therapies, and the presence of a strong pipeline of drugs under trial are the major factors boosting the market growth.

As per the American Cancer Society report, the population of cancer survivors in the US is expected to grow from ~16.9 million (since January 2019) to 22.1 million by January 2030 due to the rising aging population. Therefore, the demand for biologics such as monoclonal antibodies (mAbs) is high owing to the rising prevalence of cancer and other chronic diseases. Biologics play a key role in cancer treatment due to the presence of its principal components in many therapeutic regimens and the cost-effectiveness of treatment for patients.

Most licensed mAbs effectively treat noncommunicable diseases, including cancers and autoimmune diseases. Furthermore, successful immunotherapies involving more than 40 licensed mAbs are efficient for revolutionizing cancer treatment and have significantly improved patients' overall and long-term survival compared to traditional approaches such as chemotherapy.

According to the International AIDS Vaccine Initiative (IAVI) report, the development of mAbs is one of the fastest-growing segments of biomedical research. Further, more than 50 mAbs were licensed in the last six years, and in 2019, seven of the ten best-selling novel drugs for cancer and autoimmune diseases were mAbs. Further, the demand for mAbs has increased with the growing number of noncommunicable and infectious diseases for which mAbs are or might prove effective treatment. The sale of mAbs is predominant in the US, Canada, and Europe. Also, in terms of availability of mAbs in middle-income countries, India represents one of the most ideal countries, largely due to extensive biosimilar manufacturing capacity.

Moreover, several countries are taking strong initiatives to shorten the regulatory process for mAbs that are effective in the treatment of chronic diseases. For example, the Chinese Food and Drug Administration (CFDA), in 2017, announced a collaboration with the International Council for Harmonization to align regulatory processes relating to international standards, resulting in the approval of a number of mAbs, annually. In early 2019, the CFDA approved three mAbs from domestic developers and ten mAbs from multinational pharmaceutical companies. Such factors are stimulating the uptake of mAbs, which is contributing to the monoclonal antibody diagnostic reagent market growth.

Tests Insights

Based on tests, the monoclonal antibody diagnostic reagent market is segmented into double antigen sandwich chemiluminescence method, enzyme linked immunosorbent, assay recombinant immunoblot assay, and dot-immunogold filtration assay. The enzyme-linked immunosorbent assay segment is likely to hold the largest market share in 2022, and it is anticipated to register the highest CAGR during the forecast period. The rise in the number of chronic diseases increases the demand for the enzyme-linked immunosorbent assay (ELISA) tests for the diagnosis of hepatitis, AIDs, influenza, herpes simplex, chlamydia infections, and cancer, which is driving the growth of the enzyme-linked immunosorbent assay segment.

Application-Based Insights

Based on application, the monoclonal antibody diagnostic reagent market is segmented into hormones diagnosis, tumor monitoring, virus detection, and others. The tumor monitoring segment is likely to hold the largest market share in 2022, and it is expected to register the highest CAGR from 2022 to 2028. Monoclonal antibody diagnostic reagents are widely used in the field of cancer diagnostics. The use of antibodies linked with fluorescent dyes or enzymes enables the detection of cancer and also determines the type of cancer. All these factors are driving the growth of the tumor monitoring segment.

The National Center for Biotechnology Information (NCBI), Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Food and Drug Administration (FDA), American Society of Clinical Oncology (ASCO), Canadian Cancer Statistics, GTAI (Germany Trade and Invest), Health Ministry of Spain, Business Monitor International, National Institute of Population and Social Security Research Japan, Department of Health-Abu Dhabi, Globocan, Department of Emergency Medicine, and International AIDS Vaccine Initiative (IAVI) report are among the primary and secondary sources referred to while preparing the report on the monoclonal antibody diagnostic reagent market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the monoclonal antibody diagnostic reagent market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global monoclonal antibody diagnostic reagent market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Product Code: TIPRE00027682

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Monoclonal Antibody Diagnostic Reagent Market - By Tests
    • 1.3.2 Global Monoclonal Antibody Diagnostic Reagent Market - By Application
    • 1.3.3 Global Monoclonal Antibody Diagnostic Reagent Market - By Geography

2. Monoclonal Antibody Diagnostic Reagent Market- Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Monoclonal Antibody Diagnostic Reagent Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East & Africa - PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Monoclonal Antibody Diagnostic Reagent Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Cancer and Other Chronic Diseases
    • 5.1.2 Extensive R&D Efforts to Develop Novel Therapies
    • 5.1.3 Presence of Strong Pipeline of Drugs Under Trial
  • 5.2 Market Restraints
    • 5.2.1 Low Awareness, Accessibility, and High Cost
  • 5.3 Market Opportunities
    • 5.3.1 Cost-effective Advanced Technology for Developing mAbs Presents Billion-Dollar Opportunity
  • 5.4 Future Trends
    • 5.4.1 Strategic Research Collaborations
  • 5.5 Impact Analysis

6. Monoclonal Antibody Diagnostic Reagent Market - Global Analysis

  • 6.1 Global Monoclonal Antibody Diagnostic Reagent Market - Revenue Forecast and Analysis
    • 6.1.1 Global Monoclonal Antibody Diagnostic Reagent Market, By Geography - Forecast and Analysis
    • 6.1.2 Global Monoclonal Antibody Diagnostic Reagent Market - Market Potential Analysis, By Region
  • 6.2 Company Analysis
    • 6.2.1 Market Positioning of Key Players
    • 6.2.2 Comparative Company Analysis
    • 6.2.3 Growth Strategy Analysis
    • 6.2.4 Performance of Key Players
      • 6.2.4.1 Thermo Fisher Scientific Inc.
      • 6.2.4.2 Bio-Rad Laboratories, Inc.

7. Global Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028 - by Tests

  • 7.1 Overview
  • 7.2 Global Monoclonal Antibody Diagnostic Reagent Market, By Tests, 2021 & 2028 (%)
  • 7.3 Double Antigen Sandwich Chemiluminescence Method
    • 7.3.1 Overview
    • 7.3.2 Double Antigen Sandwich Chemiluminescence Method: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.4 Enzyme Linked Immunosorbent Assay (ELISA)
    • 7.4.1 Overview
    • 7.4.2 Enzyme Linked Immunosorbent Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.5 Recombinant Immunoblot Assay (RIBA)
    • 7.5.1 Overview
    • 7.5.2 Recombinant Immunoblot Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.6 Dot-immunogold Filtration Assay
    • 7.6.1 Overview
    • 7.6.2 Dot-immunogold Filtration Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)

8. Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 - Application

  • 8.1 Overview
  • 8.2 Global Monoclonal Antibody Diagnostic Reagent Market Share by Application Segment - 2021 & 2028 (%)
  • 8.3 Hormones Diagnosis
    • 8.3.1 Overview
    • 8.3.2 Hormones Diagnosis: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Tumor Monitoring
    • 8.4.1 Overview
    • 8.4.2 Tumor Monitoring: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Virus Detection
    • 8.5.1 Overview
    • 8.5.2 Virus Detection: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Other Applications
    • 8.6.1 Overview
    • 8.6.2 Other Applications: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)

9. Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 - Geographical Analysis

  • 9.1 North America: Monoclonal Antibody Diagnostic Reagent Market
    • 9.1.1 Overview
    • 9.1.2 North America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.1.3 North America: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
    • 9.1.4 North America: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
    • 9.1.5 North America: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)
      • 9.1.5.1 US: Monoclonal Antibody Diagnostic Reagent Market- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.1 Overview
        • 9.1.5.1.2 US: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.3 US: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.1.5.1.4 US: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
      • 9.1.5.2 Canada: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.1 Overview
        • 9.1.5.2.2 Canada: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.3 Canada: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.1.5.2.4 Canada: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
      • 9.1.5.3 Mexico: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.1 Overview
        • 9.1.5.3.2 Mexico: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.3 Mexico: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.1.5.3.4 Mexico: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
  • 9.2 Europe: Monoclonal Antibody Diagnostic Reagent Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.3 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
    • 9.2.4 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.5 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)
      • 9.2.5.1 UK: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.1 Overview
        • 9.2.5.1.2 UK: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.3 UK: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.4 UK: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.2 Germany: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.1 Overview
        • 9.2.5.2.2 Germany: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.3 Germany: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.4 Germany: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.3 France: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.1 Overview
        • 9.2.5.3.2 France: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.3 France: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.4 France: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.4 Italy: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.1 Overview
        • 9.2.5.4.2 Italy: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.3 Italy: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.4 Italy: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.5 Spain: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.1 Overview
        • 9.2.5.5.2 Spain: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.3 Spain: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.4 Spain: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.6 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.1 Overview
        • 9.2.5.6.2 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.3 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.4 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • 9.3 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.3.3 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
    • 9.3.4 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
    • 9.3.5 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)
      • 9.3.5.1 China: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.1.1 Overview
        • 9.3.5.1.2 China: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.1.3 China: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.3.5.1.4 China: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
      • 9.3.5.2 Japan: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.1 Overview
        • 9.3.5.2.2 Japan: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.3 Japan: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.3.5.2.4 Japan: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
      • 9.3.5.3 India: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.3.1 Overview
        • 9.3.5.3.2 India: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.3.3 India: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.3.5.3.4 India: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
      • 9.3.5.4 South Korea: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.1 South Korea: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.2 South Korea: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.3.5.4.3 South Korea: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
      • 9.3.5.5 Australia: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.1 Australia: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.2 Australia: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.3.5.5.3 Australia: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
      • 9.3.5.6 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.1 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.2 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019-2028 (US$ Million)
        • 9.3.5.6.3 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019-2028 (US$ Million)
  • 9.4 Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
    • 9.4.3 Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
    • 9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)
    • 9.4.5 Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)
      • 9.4.5.1 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.1.1 Overview
        • 9.4.5.1.2 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.1.3 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
        • 9.4.5.1.4 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028, By Application (US$ Million)
      • 9.4.5.2 South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.2.1 Overview
        • 9.4.5.2.2 South Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.2.3 South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
        • 9.4.5.2.4 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Application (US$ Million)
      • 9.4.5.3 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.3.1 Overview
        • 9.4.5.3.2 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.3.3 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
        • 9.4.5.3.4 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028, By Application (US$ Million)
      • 9.4.5.4 Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.4.1 Overview
        • 9.4.5.4.2 Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.4.3 Rest of Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
        • 9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By Application (US$ Million)
  • 9.5 South And Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts To 2028
    • 9.5.1 Overview
    • 9.5.2 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
    • 9.5.3 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
    • 9.5.4 South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 9.5.5 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Country (%)
      • 9.5.5.1 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.5.5.1.1 Overview
        • 9.5.5.1.2 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.5.5.1.3 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
        • 9.5.5.1.4 Brazil: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 9.5.5.2 Argentina: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028 (US$ Million)
        • 9.5.5.2.1 Overview
        • 9.5.5.2.2 Argentina Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.5.5.2.3 Argentina: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
        • 9.5.5.2.4 Argentina: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 9.5.5.3 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market- Revenue and Forecast to 2028 (USD Mn)
        • 9.5.5.3.1 Overview
        • 9.5.5.3.2 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market- Revenue and Forecast to 2028 (USD Mn)
        • 9.5.5.3.3 Rest of South & Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028, By Tests (US$ Million)
        • 9.5.5.3.4 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10. Impact Of COVID-19 Pandemic on Monoclonal Antibody Diagnostic Reagent Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Monoclonal Antibody Diagnostic Reagent Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Monoclonal Antibody Diagnostic Reagent Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 BioGenex
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories, Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Biocare Medical, LLC
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Celltrion Healthcare Co.,Ltd.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Creative Diagnostics
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 GenWay Biotech
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Thermo Fisher Scientific Inc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 ABclonal, Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Apto-Gen
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Abcam plc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms for Benign Prostatic Hyperplasia Devices Market
Product Code: TIPRE00027682

List Of Tables

  • Table 1. North America Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. US Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Canada Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Canada Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Mexico Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Mexico Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. UK: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. UK: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Germany: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Germany: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. France: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 16. France: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Italy: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Italy: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Spain: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Spain: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. China Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. China Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Japan Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Japan Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 29. India Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. India Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 31. South Korea Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. South Korea Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Australia Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Australia Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
  • Table 38. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 39. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
  • Table 40. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 41. South Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
  • Table 42. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 43. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
  • Table 44. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 45. Rest of Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
  • Table 46. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 47. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
  • Table 48. South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
  • Table 50. Brazil: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Argentina: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
  • Table 52. Argentina: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of South & Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028, By Tests (US$ Million)
  • Table 54. Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Organic Developments in the Monoclonal Antibody Diagnostic Reagent Market
  • Table 56. Inorganic Developments in the Monoclonal Antibody Diagnostic Reagent Market
  • Table 57. Glossary of Terms

List Of Figures

  • Figure 1. Monoclonal Antibody Diagnostic Reagent Market Segmentation
  • Figure 2. Monoclonal Antibody Diagnostic Reagent Market, By Region
  • Figure 3. Global Monoclonal Antibody Diagnostic Reagent Market Overview
  • Figure 4. Enzyme Linked Immunosorbent Segment Held Largest Share of Tests Segment in Monoclonal Antibody Diagnostic Reagent Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Monoclonal Antibody Diagnostic Reagent Market, by Geography (US$ Million)
  • Figure 7. Global Monoclonal Antibody Diagnostic Reagent Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Monoclonal Antibody Diagnostic Reagent Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Impact Analysis of Drivers and Restraints Pertaining to Monoclonal Antibody Diagnostic Reagent Market
  • Figure 15. Global Monoclonal Antibody Diagnostic Reagent Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 16. Global Monoclonal Antibody Diagnostic Reagent Market - By Geography Forecast and Analysis - 2022- 2028
  • Figure 17. Global Monoclonal Antibody Diagnostic Reagent Market - Market Potential Analysis, By Region
  • Figure 18. Market Positioning of Key Players in Global Monoclonal Antibody Diagnostic Reagent Market
  • Figure 19. Global Monoclonal Antibody Diagnostic Reagent Market - Comparative Company Analysis
  • Figure 20. Global Monoclonal Antibody Diagnostic Reagent Market - Growth Strategy Analysis
  • Figure 21. Global Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2021 & 2028 (%)
  • Figure 22. Double Antigen Sandwich Chemiluminescence Method: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 23. Enzyme Linked Immunosorbent Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 24. Recombinant Immunoblot Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 25. Dot-immunogold Filtration Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 26. Global Monoclonal Antibody Diagnostic Reagent Market Share by Application Segment - 2021 & 2028 (%)
  • Figure 27. Hormones Diagnosis: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 28. Tumor Monitoring: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 29. Virus Detection: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 30. Other Applications: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 31. North America: Monoclonal Antibody Diagnostic Reagent Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 32. North America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. North America: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)
  • Figure 34. US: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Canada: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Mexico: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 38. Europe: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)
  • Figure 40. UK: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Germany: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. France: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Italy: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Spain: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 47. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)
  • Figure 49. China: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Japan: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. India: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. South Korea: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Australia: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 56. Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)
  • Figure 58. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. South and Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue Overview, by Country, 2022 (US$ Million)
  • Figure 63. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 64. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 65. Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 66. Argentina Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 67. Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market- Revenue and Forecast to 2028 (USD Mn)
  • Figure 68. Impact of COVID-19 Pandemic in North American Countries Markets
  • Figure 69. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 70. Impact of COVID-19 Pandemic in Asia-Pacific Countries Markets
  • Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 72. Impact of COVID-19 Pandemic in South and Central America Africa Country Markets
  • Figure 73. Growth Strategies in the Monoclonal Antibody Diagnostic Reagent Market (%)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!